COVID-19 Hyper Coagulability Care by LLLT

Effect of Low Level Laser Therapy on Hyper Coagulability in Patients With Covid-19

COVID-19 clotting Safety

Covid-19 patients have liability for hyper coagulability, low level laser Therapy improve circulation and decrease liability for hyper coagulability accompanied with circulatory exercises .

Inclusion Criteria:

• BMI from 18.5 to 29.9 kg/m2
• Moderate elevated percentage of coagulative factors for COVID-19 Diagnosis:
• Nasopharyngeal swab
• Sepsis induced coagulopathy score>4
• D_dimer≥0,5mg/L
• Fibrinogen>2,5gm/L
• C_reactive protein≥10mg/L
• Lymphocyte count<1,500mm3
• Platelet count<150,000mm3
• Prothrombin time increase>3sec
• Activated partial thromboplastin time increase>5sec
• Same level of physical activity
• Patients can swallow tablets
• CT scan screening method for COVID-19 Diagnosis
• Physical examination

Exclusion Criteria:

• hyper tension
• Cognitive impairment e.g (delirium)
• Diabetes mellitus both types dependant or non
• Disabled musculoskeletal Disorders e.g hemi paresis
• Coronary artery diseases and heart failure
• DVT
• Stroke, bone disease, renal failure, pulmonary embolism
• Vitamins deficiency
• 6 months post large surgeries
• Alcohol intake and smokers
• Thyroid diseases